Literature DB >> 7258254

Pregnancy in cystic fibrosis: a better prognosis in patients with pancreatic function?

C W Corkey, C J Newth, M Corey, H Levison.   

Abstract

Pregnancy in patients with cystic fibrosis is likely to become a more common occurrence as a result of improving survival rates in females with this condition. Eleven pregnancies in seven patients with cystic fibrosis are presented. Despite previous reports on the hazards of pregnancy in women with cystic fibrosis, only one pregnancy required a therapeutic abortion to preserve the health of the mother. Nine of the pregnancies occurred in five mothers who had no pancreatic insufficiency, and no significant deterioration in pulmonary function occurred during or after pregnancy. These patients who do not require pancreatic enzyme supplementation appear to represent a special subgroup within cystic fibrosis in whom not only pulmonary function but also the overall prognosis is better, and in whom pregnancy can be tolerated without undue hazard.

Entities:  

Mesh:

Year:  1981        PMID: 7258254     DOI: 10.1016/0002-9378(81)90732-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

Review 1.  Women with cystic fibrosis and their potential for reproduction.

Authors:  F P Edenborough
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

2.  Reproductive issues in adults with cystic fibrosis: Implications for genetic counseling.

Authors:  A Lemke
Journal:  J Genet Couns       Date:  1992-09       Impact factor: 2.537

3.  Pregnancy in patients with cystic fibrosis.

Authors:  G J Canny
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

Review 4.  Cystic fibrosis in pregnancy.

Authors:  N E Kent; D F Farquharson
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

5.  Outcome of pregnancy in women with cystic fibrosis.

Authors:  F P Edenborough; D E Stableforth; A K Webb; W E Mackenzie; D L Smith
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.